Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024)
Baxter International's (BAX) quarterly Income from Non-Controlling Interests came in at $2.0 million in Q4 2024, up 133.33% year-on-year from $857142.9 in Q1 2024, and little changed on a QoQ basis from $2.0 million in Q1 2024.
Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024) Analysis & Trends
Baxter International (BAX) has 9 years of Income from Non-Controlling Interests data on file, last reported at $2.0 million in Q4 2024.
- On a quarterly basis, Income from Non-Controlling Interests rose 133.33% year-over-year to $2.0 million in Q4 2024; TTM through Sep 2025 was $2.0 million, a 150.0% increase from a year earlier, with the FY2024 full-year figure at $11.0 million, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q4 2024 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for BAX reached as high as $4.0 million in Q4 2021 and fell as low as -$6.0 million in Q4 2023.
- Historically, Income from Non-Controlling Interests has averaged $1.9 million across 5 years, with a median of $2.0 million in 2021.
- Across the five-year window, Income from Non-Controlling Interests surged 200.0% in 2021 and tumbled 250.0% in 2023, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $3.0 million in 2020, then soared by 33.33% to $4.0 million in 2021, then changed by 0.0% to $4.0 million in 2022, then tumbled by 250.0% to -$6.0 million in 2023, then surged by 133.33% to $2.0 million in 2024.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $2.0 million in Q4 2024, $2.0 million in Q1 2024, and -$6.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.93 Bn | 119.72 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.32 Bn | 43.51 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.04 Bn | 31.39 Bn | 1.53 Bn | - |
| 4 | Medline | 32.73 Bn | 30.49 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 28.99 Bn | 27.33 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.61 Bn | 23.18 Bn | 329.20 Mn | - |
| 7 | Solventum | 13.91 Bn | 13.35 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.25 Bn | 11.19 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.92 Bn | 9.91 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -6.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 1.00 Mn |
| Dec 31, 2019 | 4.00 Mn |
| Sep 30, 2019 | 6.00 Mn |